MT Newswires
Moleculin Biotech Says Japan Patent Office Issues Notice of Allowance for Patent Covering Annamycin; Shares Rise Pre-Bell
📊
AI Sentiment
Positive
7/10
- Home
- MBRX
as of 02-19-2026 3:59pm EST
$2.68
$2.13
-44.33%
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
| Founded: | 2015 | Country: | US |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 12.8M | IPO Year: | 2016 |
| Target Price: | $105.50 | AVG Volume (30 days): | 97.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.25 - $7.98 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -2.03 | Index: | N/A |
| Free Cash Flow: | -23875000.0 | FCF Growth: | N/A |
AI-Powered MBRX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 75.36%
75.36%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Moleculin Biotech Inc. News
MBRX Breaking Stock News: Dive into MBRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Moleculin Launches CEO Corner Platform to Share Strategic Insights
📊
AI Sentiment
Positive
7/10
Compare MBRX vs Leading Stocks
See how MBRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MBRX Moleculin Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.